Verapharm SRL
0.5 FTEThe score of Verapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +5 % Total assets +10 % Headcount (avg FTE) +25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Verapharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 37,249 € | ||||
| Equity | 232,349 € | ||||
| Cash | 126,282 € | ||||
| EBITDA | 75,063 € | ||||
| Total assets | 327,020 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Verapharm's financial analysis
- Solvency71.1%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Verapharm
Verapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.036.577
- VAT number
- BE0479036577
- Peppol
- Registered · 0208:0479036577 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Dec 2002
- Registered office
- 1200 Woluwe-Saint-Lambert
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Verapharm (SRL) has been based in Woluwe-Saint-Lambert since 2002, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 37,249 € and equity of 232,349 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 71.1%, above the median of its sector (37.8%).
Companies similar to Verapharm
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Tanghe - Vanneste Retail sale of pharmaceutical products Pajottegem · balance sheet 318,191 €
- Pharmacie Siraut Retail sale of pharmaceutical products Mons · balance sheet 327,340 €
- Medi Falcon Retail sale of pharmaceutical products Aalst · balance sheet 328,898 €
- Geassocieerde Apotheek Ekeren Retail sale of pharmaceutical products Antwerp · balance sheet 331,202 €
- Pharma-Thuillies Retail sale of pharmaceutical products Thuin · balance sheet 400,573 €
- Apoteek DE Smedt Retail sale of pharmaceutical products Asse · balance sheet 343,684 €
- Milan Apotica Retail sale of pharmaceutical products Waterloo · balance sheet 321,144 €
- Vision 2017 Retail sale of pharmaceutical products Schaerbeek · balance sheet 318,760 €
Frequently asked questions about Verapharm
What is the revenue of Verapharm?
Verapharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Verapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0479036577 for Verapharm, if the company is VAT-registered. Its company number (CBE) is 0479.036.577.
Where is the registered office of Verapharm?
According to the CBE register, the registered office of Verapharm is in 1200 Woluwe-Saint-Lambert.
What is the equity of Verapharm?
At the close of the 2025 financial year, the equity of Verapharm amounts to 232,349 €, a solvency of 71.1% of total assets.
How many people work at Verapharm?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Verapharm?
The register lists 1 active mandates at Verapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Verapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →